论文部分内容阅读
目的探讨缩宫素联合米索前列醇预防产后出血效果。方法本次实验以我院2010年1月至2011年1月所收治的100例产妇为实验对象,将患者随机分为实验组和对照组两组,对照组患者仅使用缩宫素进行治疗,实验组患者接受缩宫素联合米索前列醇治疗,对比分析两组患者的临床治疗效果。结果实验组患者经过治疗,产后出血发生率、产后2h出血量、第三产程时间和不良反应发生率等均显著优于对照组患者,两组患者的实验数据对比差异有统计学意义(P<0.05)。结论本次实验结果表明,缩宫素联合米索前列醇用于预防产后出血,具有十分理想的临床疗效,且治疗的安全性和可靠性更高,是一种较为理想的产后出血预防措施。
Objective To investigate the effect of oxytocin combined with misoprostol in preventing postpartum hemorrhage. Methods In this experiment, 100 maternal women admitted to our hospital from January 2010 to January 2011 were selected as the experimental subjects. The patients were randomly divided into experimental group and control group. Patients in the control group were treated with oxytocin only, Patients in the experimental group received oxytocin combined with misoprostol, and compared the clinical effects of the two groups. Results After treatment, the incidence of postpartum hemorrhage, the amount of bleeding at 2h postpartum, the time of the third stage of labor and the incidence of adverse reactions in the experimental group were significantly better than those in the control group. There was significant difference in the experimental data between the two groups (P < 0.05). Conclusion The experimental results show that oxytocin combined with misoprostol for the prevention of postpartum hemorrhage, has a very good clinical efficacy, and the treatment of higher safety and reliability, is an ideal measure of prevention of postpartum hemorrhage.